title: Response to: Comparison of infliximab drug measurement across three commercially available ELISA kits: author reply.
authors.affiliation: University of NSW, Sydney, Australia; Sydney South West Pathology Service, Liverpool Hospital, Sydney, Australia. Electronic address: catherine.toong@sswahs.nsw.gov.au.
authors.forename: Catherine Mei-Ling
authors.initials: CM
authors.lastname: Toong
authors.affiliation: Department of Immunology, Liverpool Hospital, Sydney, (currently practising at Immunology Department, Campbelltown Hospital, Campbelltown), Australia.
authors.forename: Monique Wei Meng
authors.initials: MW
authors.lastname: Lee
authors.affiliation: University of NSW, Sydney, Australia; Department of Gastroenterology and Hepatology, Liverpool Hospital, Sydney, NSW, Australia.
authors.forename: Susan
authors.initials: S
authors.lastname: Connor
authors.affiliation: Department of Gastroenterology and Hepatology, Liverpool Hospital, Sydney, NSW, Australia.
authors.forename: Watson
authors.initials: W
authors.lastname: Ng
mesh_terms: D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D000069285:Infliximab; D011933:Reagent Kits, Diagnostic
chemical_list: D011933:Reagent Kits, Diagnostic; D000069285:Infliximab